Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
AMPRONIX
SCHILLER AG

Higher-End Diagnostic Imaging Uptake Fending off Market Maturity in Europe

By Medimaging International staff writers
Posted on 25 Feb 2013
The rising prevalence of unhealthy lifestyles and increasing elderly population and in Europe will fuel demand for diagnostic imaging procedures. The European diagnostic imaging system market is forecast to expand slightly, to nearly USD 2.2 billion in 2017, according to recent market research.

Although the effects of the European debt crisis will continue to hamper the market to some extent by delaying buying capital equipment in the next few years, economic conditions will slowly recover after 2013. As aging systems are finally replaced and more facilities purchase high-end imaging systems, system revenues will gather speed, with the magnetic resonance imaging (MRI) and computed tomography (CT) system markets growing the fastest through 2017, according to Millennium Research Group (MRG; Toronto, Canada), a global company focused on medical technology market intelligence.

Higher-end systems are being purchased in these segments, particularly in the CT system market, because they offer sophisticated features and effective images. In addition to higher-quality, facilities will also seek to purchase high-end systems with better dose management features—a significant consideration given the community’s ongoing emphasis on reducing radiation doses.

Likewise, the market will show an ongoing shift in preference for higher-end direct radiography (DR) X-ray systems as facilities try to become more efficient. “The shift to DR X-ray systems is somewhat of a double-edged sword,” said MRG analyst Felix Lam. “These premium systems are fueling revenues, but their efficiency in patient throughput also means that one DR system can replace multiple analog and computed radiography systems.”

The European diagnostic imaging system market is led by multisegment vendors GE Healthcare (Chalfont St. Giles, UK), Siemens Healthcare (Erlangen, Germany), and Philips Healthcare (Best, The Netherlands), which compete across a range imaging modalities. The strength of these companies lies in their leading positions in the MRI and CT system markets, the critical segments for the near future.

Millennium Research Group, a Decision Resources Group company, is a global specialist on medical technology market intelligence and a provider of strategic information to the healthcare sector.

Related Links:

Millennium Research Group




SuperSonic Imagine
RADCAL
RTI ELECTRONICS AB

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

MRI

view channel

Use of Breast MRI Offers Optimized Care

Magnetic resonance imaging (MRI) is being used increasingly for breast cancer screening, diagnostic assessment, treatment planning, and monitoring; however, a recent study revealed that over time, the indication for breast MRI has changed. Much of the increase was found among women with breast cancer risk factors, but there... Read more

Ultrasound

view channel
Image: Analogic Sonic Window handheld ultrasound for peripheral IV placement (Photo courtesy of Analogic).

First-of-a-Kind Ultrasound System Designed for Image-Guided Peripheral Intravenous Access and Fits in Pocket

A new, ultra-compact ultrasound device provides direct visualization of structures beneath the skin in real time to effectively guide clinicians placing peripheral intravenous (IV) lines.... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.